MHMahsa Jafari Harandi

Mahsa Jafari Harandi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mahsa Jafari Harandi has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment

    by Parisa Aziminezhadan, Mahsa Jafari Harandi, Faranak Olamaeian, Mohammadjavad Ashoori, Ali Tayebi

    Intraductal papillomas (IDPs) are benign breast lesions with potential for malignant transformation. This study aimed to determine the upgrade rate of de-novo IDPs to malignancy, identify associated risk factors, and assess the 6-month outcome after treatment. This retrospective cohort study included 320 patients diagnosed with de-novo IDP at a breast surgery clinic in Tehran, Iran, between March 2011 and March 2022. Patients were divided into upgraded (malignant) and non-upgraded (benign) groups based on pathology results from core needle biopsy (CNB) or vacuum-assisted excision (VAE). Baseline characteristics, pathology outcomes, and follow-up outcomes were analyzed. Multivariable logistic regression identified risk factors for malignant upgrade. Of the 320 participants, 16 (5.0%) had upgraded (malignant) IDPs, and 304 (95.0%) had non-upgraded (benign) IDPs. The median age was significantly higher in the upgraded group (53 years) compared to the non-upgraded group (43 years) (p < 0.001). Age ≥ 50 years was a significant risk factor for malignant upgrade (, p < 0.001). The most common malignant pathology was ductal carcinoma in situ (DCIS) (68.8%). Age was identified as a significant risk factor for malignancy, with older age increasing the likelihood of an upgrade (OR = 1.249, p = 0.02). After 6 months follow-up, three patients with IDP were detected by sonography. Older age was the sole significant risk factor for malignant transformation of IDPs. Continuous follow-up is recommended, especially for older patients, to promptly detect potential recurrence or malignant progression.